CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹17,448 Cr | ₹13,454 Cr | ₹12,689 Cr | ₹11,732 Cr | ₹11,925 Cr |
What is the latest Total Non-Current Assets ratio of CIPLA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹17,448 Cr |
| Mar2025 | ₹13,454 Cr |
| Mar2024 | ₹12,689 Cr |
| Mar2023 | ₹11,732 Cr |
| Mar2022 | ₹11,925 Cr |
How is Total Non-Current Assets of CIPLA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹17,448 Cr | 29.69 | |
| Mar2025 | ₹13,454 Cr | 6.03 | |
| Mar2024 | ₹12,689 Cr | 8.16 | |
| Mar2023 | ₹11,732 Cr | -1.62 | |
| Mar2022 | ₹11,925 Cr | - | |
Compare Total Non-Current Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹111,732.6 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| MANKIND PHARMA | ₹107,613.0 Cr | -1.9% | 14.5% | 15.5% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -2.4% |
4.4% |
-8.3% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses